BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6989485)

  • 1. Serum copper levels in non-Hodgkin's lymphoma.
    Shah-Reddy I; Khilanani P; Bishop CR
    Cancer; 1980 Apr; 45(8):2156-9. PubMed ID: 6989485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum copper and zinc levels and copper/zinc ratio in pediatric non-Hodgkin's lymphoma.
    Gözdaşoğlu S; Cavdar AO; Arcasoy A; Akar N
    Acta Haematol; 1982; 67(1):67-70. PubMed ID: 6800204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
    Margerison AC; Mann JR
    Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of serum copper levels in non-Hodgkin's lymphoma.
    Cohen Y; Epelbaum R; Haim N; McShan D; Zinder O
    Cancer; 1984 Jan; 53(2):296-300. PubMed ID: 6690011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical markers in Hodgkin's disease and non-Hodgkin's lymphoma.
    Child JA; Cooper EH; Illingworth S; Worthy TS
    Recent Results Cancer Res; 1978; 64():180-9. PubMed ID: 366696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum LDH concentration in non-Hodgkin's lymphomas. Relationship to histologic type, tumor mass, and presentation features.
    Fasola G; Fanin R; Gherlinzoni F; Galieni P; Taruscio D; Frezza G; Mazza P; Pileri S; Baccarani M
    Acta Haematol; 1984; 72(4):231-8. PubMed ID: 6438991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum copper levels in lymphoma and leukemia. Special reference to Hodgkin's disease.
    Hrgovcic M; Tessmer CF; Minckler TM; Mosier B; Taylor GH
    Cancer; 1968 Apr; 21(4):743-55. PubMed ID: 4868473
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum copper level in non-Hodgkin's lymphomas.
    Salvagno L; Pappagallo GL; Chiarion Sileni V; Segati R; Cartei G; Endrizzi L; Paccagnella A; Ongaro G; Bonvicini P; Fiorentino MV
    Tumori; 1982 Feb; 68(1):57-62. PubMed ID: 7071946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum trace elements and Cu/Zn ratio in malignant lymphomas in children.
    Gupta SK; Shukla VK; Gupta V; Gupta S
    J Trop Pediatr; 1994 Jun; 40(3):185-7. PubMed ID: 8078119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of ceruloplasmin, properdin factor B and copper in lymphoma patients.
    Casamassima A; Addabbo L; Caporusso L; Lorusso V
    Int J Biol Markers; 1991; 6(3):183-7. PubMed ID: 1791312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum copper compared to erythrocyte sedimentation rate as indicator of disease activity in Hodgkin's disease.
    Asbjörnsen G
    Scand J Haematol; 1979 Mar; 22(3):193-6. PubMed ID: 451449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study on serum copper and zinc levels and copper/zinc ratio in malignant lymphoma].
    Wu HY
    Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):335-8. PubMed ID: 3248498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Hodgkin's lymphoma in children.
    Pinkel D; Johnson W; Aur RJ
    Br J Cancer Suppl; 1975 Mar; 2():298-323. PubMed ID: 1101924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron, copper, and zinc liver tissue levels in patients with malignant lymphomas.
    Roguljić A; Roth A; KolariC K; Maricić Z
    Cancer; 1980 Aug; 46(3):565-9. PubMed ID: 6994869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. So-called "Lennert's lymphoma": is it a clinicopathologic entity?
    Kim H; Nathwani BN; Rappaport H
    Cancer; 1980 Mar; 45(6):1379-99. PubMed ID: 6986978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of combination chemotherapy of non-Hodgkin's lymphoma.
    Schein PS; Chabner BA; Canellos GP; Young RD; Berard C; DeVita VT
    Br J Cancer Suppl; 1975 Mar; 2():465-73. PubMed ID: 1101932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of hypercupremia with other acute phase reactants in malignant lymphoma.
    Shah I; Lewkow LM; Khilanani U
    Cancer; 1983 Mar; 51(5):851-4. PubMed ID: 6401595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease.
    Krikorian JG; Burke JS; Rosenberg SA; Kaplan HS
    N Engl J Med; 1979 Mar; 300(9):452-8. PubMed ID: 366418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.